Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.3600
+0.0142 (4.11%)
Jun 17, 2025, 12:19 PM - Market open
Renovaro Market Cap
Renovaro has a market cap or net worth of $61.96 million as of June 17, 2025. Its market cap has decreased by -71.42% in one year.
Market Cap
61.96M
Enterprise Value
65.46M
1-Year Change
-71.42%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since December 11, 2018, Renovaro's market cap has decreased from $252.00M to $61.96M, a decrease of -75.41%. That is a compound annual growth rate of -19.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 59.60M | -55.09% |
| Dec 31, 2024 | 132.70M | -37.23% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |